Clinical Trial Update: Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of SGLT2 inhibition on albuminuria levels in patients with type 2 diabetes and diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Type 2 Diabetes, Diabetic Nephropathy | Phase 4 | Status: UNKNOWN